Why is PointsBet (ASX:PBH) raising $400 million?

This sports betting company is raising $400 million from investors. Here's why…

| More on:
Happy young man and woman throwing dividend cash into air in front of orange background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The PointsBet Holdings Ltd (ASX: PBH) share price is missing out on the market's gains on Thursday.

This is because the sports betting company requested a trading halt prior to the market open.

Why is the PointsBet share price halted?

The PointsBet share price was placed in a trading halt this morning so the company could launch an underwritten capital raising.

According to the release, PointsBet is aiming to raise approximately $400 million. This comprises a fully underwritten 1 for 9 accelerated pro rata renounceable entitlement offer, with retail rights trading, to raise approximately $184.9 million at $8.00 per new share, and a fully underwritten institutional placement to raise $215.1 million at $10.00 per new share.

With the PointsBet share price last trading at $11.29, this means discounts of 29.1% and 11.4%, respectively.

Why is PointsBet raising funds?

Given that PointsBet just finished FY 2021 (Q4 update here) with a cash balance of $245.5 million, investors may be curious why it is raising funds at this point.

According to the release, the company is raising funds to support its objective of consolidating and expanding upon its strong position in the rapidly expanding US sports betting and iGaming market.

Funding will be used to support North American marketing and client acquisition, technology and product development, US market access and government licensing fees, and continued investment in talent and scale of operations. Management also notes it will give it balance sheet flexibility.

PointsBet's Managing Director and Group CEO, Sam Swanell, commented: "Since inception, PointsBet's Board and management have been working to establish and consolidate the key building blocks that have put us in the strong position we are today to pursue the expansion of the North American sports betting and iGaming opportunity."

"Today, in addition to our profitable Australian business, we have live operations in 6 US States with iGaming live in two of these states. By December 2022 we plan to be live in at least 19 North American states or provinces. The North American sports betting and iGaming market could be a US$54bn revenue opportunity by 2033 and our strategy is to continue to invest to become a top 5 player in this market, targeting a 10% market share in all key North American jurisdictions. The Capital Raising will position PointsBet to execute this strategy," he concluded.

Co-Founders sell-down

PointsBet Co-Founders, Andrew and Nicholas Fahey and Sam Swanell, will be selling down some of their holding.

Nick and Andrew Fahey will be selling 2 million shares and Sam Swanell will be offloading 0.9 million shares at $10.00 per share. This represents 15% of their respective interests in PointsBet.

And while Mr Swanell has confirmed that he does not intend to sell any further shares for a period of 12 months, the Faheys haven't made the same commitment.

Some of these shares will be bought by the company's Chairman, Brett Paton. He has agreed to purchase 1.45 million of the shares being sold by the Co-Founders at $10.00 per share. The remainder of the shares will be placed at the placement price with an institutional investor, independent of the capital raising.

The PointsBet share price is up 116% over the last 12 months.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Pointsbet Holdings Ltd. The Motley Fool Australia has recommended Pointsbet Holdings Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Capital Raising

A man slumps crankily over his morning coffee as it pours with rain outside.
Materials Shares

Why is this ASX 300 battery materials stock crashing 20% today?

Its shares are now down by 67% since this time last year.

Read more »

A man with a heavy facial hair growth and a comical look on his face holds his hands in a 'time out' gesture.
Energy Shares

Up 90% in a year, why is this ASX 300 uranium stock suddenly halted?

Here's why this high-flying stock is out of action today.

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Mergers & Acquisitions

Why are Metcash shares tumbling today?

This wholesaler has just received a $300 million cash injection.

Read more »

A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
Materials Shares

Why is the Arafura share price sinking 17% today?

It has been a tough session for this rare earths stock. But why?

Read more »

Two happy pharmacists standing together in a pharmacy.
Capital Raising

Own Sigma shares? Everything you need to know about the 'transformational' $8.8b merger with Chemist Warehouse

Here's what you need to know about this mega merger.

Read more »

Close up of a sad young woman reading about declining share price on her phone.
Energy Shares

Why is the Boss Energy share price sinking 5% today?

This uranium share is raising funds. But why?

Read more »

a man in a suit holds up a hand and a stop sign at a roadblock positioned over a bitumen road .
Capital Raising

Why are Boss Energy shares in a trading halt?

This uranium share is raising funds. But why?

Read more »

A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
Healthcare Shares

Why is the Mesoblast share price sinking 25% on Tuesday?

This biotech is being sold off today. But why?

Read more »